ZHEJIANG WOLWO BIO-PHARMACEUTICAL CO., LTD. Funds and ETFs Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Equities
300357
CNE100001R58
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.05 CNY | -0.21% |
|
+1.52% | -17.07% |
ETFs positioned on Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.50% | 2 M€ | -12.62% | - | |
| 0.04% | 11 M€ | +4.66% | ||
| 0.00% | 31 M€ | +5.22% | - | |
| 0.00% | 2,808 M€ | +8.23% | - | |
| 0.00% | 441 M€ | +7.05% | - | |
| 0.00% | 149 M€ | +5.36% | - | |
| 0.00% | 34 M€ | +2.67% | - | |
| 0.00% | 7 M€ | +3.48% | - | |
| 0.00% | 15 M€ | +12.19% |
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and sale of bio-pharmaceutical products. The Company's main products include Dermatophagoides Farinae Drops and Dermatophagoides Farinae Skin Prick Diagnostic Kits. The Company's products are primarily used for the treatment of allergic rhinitis caused by dust mite allergy, the desensitization of allergic asthma and the in-vivo diagnosis of dust mite drops. The Company distributes its products in domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-17
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
24.05
CNY
Average target price
27.96
CNY
Spread / Average Target
+16.24%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -17.07% | 1.74B | |
| +26.08% | 662B | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| -3.40% | 157B |
- Stock Market
- Equities
- 300357 Stock
- Funds and ETFs Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
